Crossmark

Sex differences in symptoms following the administration of BNT162b2 mRNA COVID-19 vaccine in children below 5 years of age in Germany (CoVacU5): a retrospective cohort study

Crossref DOI link: https://doi.org/10.1186/s13293-024-00651-x

Published Online: 2024-09-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moor, Jeanne

Toepfner, Nicole

von Meißner, Wolfgang C. G.

Berner, Reinhard

Moor, Matthias B.

Kublickiene, Karolina

Strumann, Christoph

Chao, Cho-Ming
Funding

Funding for this research was provided by:

Private Universität Witten/Herdecke gGmbH
License Information

Text and Data Mining valid from 2024-09-26

Version of Record valid from 2024-09-26
More Information

Article History

Received: 12 April 2024

Accepted: 14 September 2024

First Online: 26 September 2024

Declarations

:

: The study protocol was assessed and approved by the Ethics Committee of University of Rostock, Germany (ID: A 2022-0065). All participants gave informed consent via their legal guardian.

: Not applicable (no individual data).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below